FDA Approved: DOCIVYX — Original Application (Avyxa Pharma, LLC)

View source ↗

Summary

FDA approves DOCIVYX (docetaxel) under an original NDA submitted by Avyxa Pharma, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Gastric Cancer
• Head and Neck Squamous Cell Carcinoma
• Non-small Cell Lung Cancer
• Prostate Cancer

Drugs mentioned

• DOCIVYX (DOCETAXEL)

Snippet

ORIG AP for DOCIVYX (DOCETAXEL)